Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [41] A Cautionary Note: "Real-World" Toxicity of Checkpoint Inhibitors
    Markman, Maurie
    ONCOLOGY, 2018, 94 (05) : 257 - 258
  • [42] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
    Kim, Hyera
    Kwon, Minsuk
    Kim, Binnari
    Jung, Hyun Ae
    Sun, Jong-Mu
    Lee, Se-Hoon
    Park, Keunchil
    Ahn, Myung-Ju
    BMC CANCER, 2020, 20 (01)
  • [43] Immune checkpoint inhibitors in patients with solid tumors and poor performance status A prospective data from the real-world settings
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay M.
    Menon, Nandini
    Joshi, Amit
    Abraham, George
    Prabhash, Kumar
    MEDICINE, 2021, 100 (13) : E25115
  • [44] Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma
    Sun, Meiling
    Ji, Huaijun
    Xu, Ning
    Jiang, Peng
    Qu, Tao
    Li, Yu
    BMC CANCER, 2022, 22 (01)
  • [45] Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea
    Hyera Kim
    Minsuk Kwon
    Binnari Kim
    Hyun Ae Jung
    Jong-Mu Sun
    Se-Hoon Lee
    Keunchil Park
    Myung-Ju Ahn
    BMC Cancer, 20
  • [46] Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma
    Meiling Sun
    Huaijun Ji
    Ning Xu
    Peng Jiang
    Tao Qu
    Yu Li
    BMC Cancer, 22
  • [47] The association between body mass index and immune checkpoint inhibitors outcomes in melanoma: Results from real-world data
    Elantably, Dina
    Wang, Jiasheng
    Al Armashi, Abdul Rahman
    Al Zubaidi, Anas
    Alkrekshi, Akram
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
    Jain, P.
    Bugarin, J. Gutierrez
    Guha, A.
    Jain, C.
    Patil, N.
    Shen, T.
    Stanevich, I.
    Nikore, V.
    Margolin, K.
    Ernstoff, M.
    Velcheti, V.
    Barnholtz-Sloan, J.
    Dowlati, A.
    ESMO OPEN, 2021, 6 (05)
  • [49] Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay M.
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Prabhash, Kumar
    ECANCERMEDICALSCIENCE, 2020, 14
  • [50] Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
    Ruggiero, Rosanna
    Stelitano, Barbara
    Fraenza, Federica
    di Mauro, Gabriella
    Scavone, Cristina
    Sportiello, Liberata
    Rafaniello, Concetta
    Di Napoli, Raffaella
    Danesi, Romano
    Del Re, Marzia
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN ONCOLOGY, 2022, 12
12345